July 09, 2021
The development and manufacturing of biologics is highly complex, difficult and costly, because biomolecular processes rely on a variety of dynamic interactions. Investigating and testing hypotheses in silico, or via simulation, can help scientists accelerate the development of biologics and reduce the time and expense involved in bringing these therapies to patients.
Join our webinar to learn more about:
- Augment physical experimentation with in silico techniques
- Accelerate biologics characterization
- Simplify biologics lead identification/optimization